Friday, December 08, 2023 11:29:12 AM
The University of Chicago Institute for Translational Medicine and the Bucksbaum Institute for Clinical Excellence funded the research.
Skondra reported receiving consulting fees from Biogen, LaGrippe Research, Focuscope, AbbVie, Alimera Science, Trinity Life Sciences, Keywest Health, and Lumina. A co-author reported receiving personal fees from Alimera Sciences, Iveric Bio, Apellis Pharmaceuticals, Coherus BioSciences, EyePoint Pharmaceuticals, AbbVie, Biogen, and Regeneron.
Domalpally had no disclosures.
Primary Source
JAMA Ophthalmology
Source Reference: opens in a new tab or windowAggarwal S, et al "Metformin use and age-related macular degeneration in patients without diabetes" JAMA Ophthalmol 2023; DOI: 10.1001/jamaophthalmol.2023.5478.
Recent CUBT News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 05/06/2024 09:31:41 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM